AUPH Q2 2018 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000-91.2% YoY

Gross Profit

-$10M-36120.7% margin

Operating Income

-$14M-49448.3% margin

Net Income

-$16M-54162.1% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$168M

Total Liabilities

$26M

Stockholders' Equity

$142M

Cash & Equivalents

$132M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$329,000	-91.2%
Gross Profit	-$10M	-$7M	-54.5%
Operating Income	-$14M	-$10M	-42.7%
Net Income	-$16M	-$2M	-554.7%